Paper2139102
Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.
Young JW and 1 other. J Exp Med, 1990. Cited by 204 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. Papers, record 2139102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2139102
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4 Antigens | Major topic |
| Cytotoxicity, Immunologic | Major topic |
| Dendritic Cells | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| T-Lymphocytes, Helper-Inducer | Major topic |
| Antigens, CD | |
| Cell Communication | |
| Cell Separation | |
| Cells, Cultured | |
| Centrifugation, Density Gradient | |
| Humans | |
| Interleukin-2 | |
| Leukocytes | |
| Lymphocyte Culture Test, Mixed | |
| Phenotype |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R29 AI-26875 | NIAID NIH HHS | United States | R29AI026875 | PubMed and NIH | NIH RePORTER |
| KO8 CA-00961 | NCI NIH HHS | United States | K08CA000961 | PubMed and NIH | NIH RePORTER |
| P01 AI-24775 | NIAID NIH HHS | United States | P01AI024775 | PubMed and NIH | NIH RePORTER |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,450,246 | Anti-recipient cytotoxic T lymphocyte precursors are present in the spleens of mice with acute graft versus host disease due to minor histocompatibility antigens. | J Immunol | 1981 | https://conductscience.org/library/papers/6450246 | PubMed |
| 2 | 7,451,976 | Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells. | J Immunol | 1981 | https://conductscience.org/library/papers/7451976 | PubMed |
| 3 | 6,975,347 | T cell growth factor receptors. Quantitation, specificity, and biological relevance. | J Exp Med | 1981 | https://conductscience.org/library/papers/6975347 | PubMed |
| 4 | 6,977,610 | Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers. | J Exp Med | 1982 | https://conductscience.org/library/papers/6977610 | PubMed |
| 5 | 6,186,923 | A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. | Nature | 1983 | https://conductscience.org/library/papers/6186923 | PubMed |
| 6 | 6,195,259 | Alloantigen-specific cytotoxic and suppressor T lymphocytes are derived from phenotypically distinct precursors. | J Immunol | 1983 | https://conductscience.org/library/papers/6195259 | PubMed |
| 7 | 6,434,688 | Response of resting human peripheral blood natural killer cells to interleukin 2. | J Exp Med | 1984 | https://conductscience.org/library/papers/6434688 | PubMed |
| 8 | 3,871,216 | Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens. | J Immunol | 1985 | https://conductscience.org/library/papers/3871216 | PubMed |
| 9 | 6,239,901 | Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. | J Exp Med | 1984 | https://conductscience.org/library/papers/6239901 | PubMed |
| 10 | 3,894,963 | An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. | N Engl J Med | 1985 | https://conductscience.org/library/papers/3894963 | PubMed |
| 11 | 2,933,483 | Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. | J Exp Med | 1985 | https://conductscience.org/library/papers/2933483 | PubMed |
| 12 | 3,936,719 | Monoclonal antibody 9.3 and anti-CD11 antibodies define reciprocal subsets of lymphocytes. | Eur J Immunol | 1985 | https://conductscience.org/library/papers/3936719 | PubMed |
| 13 | 3,910,556 | Graft-versus-host reactions and disease. | Immunol Rev | 1985 | https://conductscience.org/library/papers/3910556 | PubMed |
| 14 | 3,910,558 | Graft-versus-host disease in dog and man: the Seattle experience. | Immunol Rev | 1985 | https://conductscience.org/library/papers/3910558 | PubMed |
| 15 | 3,512,763 | Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. | J Exp Med | 1986 | https://conductscience.org/library/papers/3512763 | PubMed |
| 16 | 2,873,281 | Graft rejection and graft-versus-host disease: mirror images. | Lancet | 1986 | https://conductscience.org/library/papers/2873281 | PubMed |
| 17 | 3,090,451 | Capacity of purified Lyt-2+ T cells to mount primary proliferative and cytotoxic responses to Ia- tumour cells. | Nature | 1986 | https://conductscience.org/library/papers/3090451 | PubMed |
| 18 | 3,108,446 | Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. | J Exp Med | 1987 | https://conductscience.org/library/papers/3108446 | PubMed |
| 19 | 2,955,054 | Mononuclear phagocytes as targets for cytolytic T lymphocytes. | J Immunol Methods | 1987 | https://conductscience.org/library/papers/2955054 | PubMed |
| 20 | 2,955,069 | Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells. | J Exp Med | 1987 | https://conductscience.org/library/papers/2955069 | PubMed |
Cited by46
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 204 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,630,477 | A data-driven cartography of NSCLC vaccine research: Quantifying the paradigm shift toward immuno-oncology combination therapies. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41630477 | PubMed |
| 41,503,128 | Neoantigen dendritic cell vaccination combined with conventional chemotherapy for a patient with advanced transverse colon cancer. | J Surg Case Rep | 2026 | https://conductscience.org/library/papers/41503128 | PubMed |
| 41,148,450 | Dendritic Cells: at the Crossroads between Oral Tolerance and Food Allergy. | Curr Allergy Asthma Rep | 2025 | https://conductscience.org/library/papers/41148450 | PubMed |
| 30,719,026 | Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy. | Front Immunol | 2018 | https://conductscience.org/library/papers/30719026 | PubMed |
| 24,211,847 | Therapeutic polyclonal human CD8+ CD25+ Fox3+ TNFR2+ PD-L1+ regulatory cells induced ex-vivo. | Clin Immunol | 2013 | https://conductscience.org/library/papers/24211847 | PubMed |
| 23,130,928 | Dendritic cell-based vaccines: barriers and opportunities. | Future Oncol | 2012 | https://conductscience.org/library/papers/23130928 | PubMed |
| 21,917,753 | Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen. | Blood | 2011 | https://conductscience.org/library/papers/21917753 | PubMed |
| 20,644,110 | Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity. | Blood | 2010 | https://conductscience.org/library/papers/20644110 | PubMed |
| 18,971,304 | Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice. | Clin Vaccine Immunol | 2008 | https://conductscience.org/library/papers/18971304 | PubMed |
| 18,798,913 | The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. | Exp Dermatol | 2008 | https://conductscience.org/library/papers/18798913 | PubMed |
| 17,420,764 | Immunology and immunotherapy approaches for prostate cancer. | Prostate Cancer Prostatic Dis | 2007 | https://conductscience.org/library/papers/17420764 | PubMed |
| 17,239,504 | Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. | Vaccine | 2007 | https://conductscience.org/library/papers/17239504 | PubMed |
| 12,663,800 | Varicella-zoster virus productively infects mature dendritic cells and alters their immune function. | J Virol | 2003 | https://conductscience.org/library/papers/12663800 | PubMed |
| 12,595,432 | Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. | Infect Immun | 2003 | https://conductscience.org/library/papers/12595432 | PubMed |
| 11,733,563 | High-affinity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11733563 | PubMed |
| 11,672,507 | HIV-1 infection of placental cord blood monocyte-derived dendritic cells. | J Hematother Stem Cell Res | 2001 | https://conductscience.org/library/papers/11672507 | PubMed |
| 11,422,197 | Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. | Clin Exp Immunol | 2001 | https://conductscience.org/library/papers/11422197 | PubMed |
| 11,067,871 | Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. | J Exp Med | 2000 | https://conductscience.org/library/papers/11067871 | PubMed |
| 11,021,596 | Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. | Gene Ther | 2000 | https://conductscience.org/library/papers/11021596 | PubMed |
| 10,888,653 | Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. | J Virol | 2000 | https://conductscience.org/library/papers/10888653 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD28 | 940 | PubTator's text mining | https://conductscience.org/library/genes/940 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FCGR3A | 2,214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| IL2RA | 3,559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| ITGAM | 3,684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
| PTPRC | 5,788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2139102
GET https://conductscience.org/api/papers/v1/2139102/references?page=2